Research Paper Volume 12, Issue 20 pp 20835—20861

SMARCD3 is a potential prognostic marker and therapeutic target in CAFs

Figure 5. Gene-Pathway interaction network of SMARCD3, CRIP2, PRAM1, HSPB2 and CERCAM in colorectal cancer.